These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Activatable cell penetrating peptide-conjugated nanoparticles with enhanced permeability for site-specific targeting delivery of anticancer drug. Xia H, Gu G, Hu Q, Liu Z, Jiang M, Kang T, Miao D, Song Q, Yao L, Tu Y, Chen H, Gao X, Chen J. Bioconjug Chem; 2013 Mar 20; 24(3):419-30. PubMed ID: 23350619 [Abstract] [Full Text] [Related]
4. Improved oral efficacy of epirubicin through polymeric nanoparticles: pharmacodynamic and toxicological investigations. Tariq M, Alam MA, Singh AT, Panda AK, Talegaonkar S. Drug Deliv; 2016 Oct 20; 23(8):2990-2997. PubMed ID: 26800371 [Abstract] [Full Text] [Related]
10. Tumor homing cell penetrating peptide decorated nanoparticles used for enhancing tumor targeting delivery and therapy. Gao H, Zhang Q, Yang Y, Jiang X, He Q. Int J Pharm; 2015 Jan 15; 478(1):240-250. PubMed ID: 25448586 [Abstract] [Full Text] [Related]
11. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation. Guo F, Zhang M, Gao Y, Zhu S, Chen S, Liu W, Zhong H, Liu J. Drug Deliv; 2016 Jul 15; 23(6):2003-14. PubMed ID: 26181840 [Abstract] [Full Text] [Related]
17. Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin. Chen H, Xie LQ, Qin J, Jia Y, Cai X, Nan W, Yang W, Lv F, Zhang QQ. Colloids Surf B Biointerfaces; 2016 Feb 01; 138():1-9. PubMed ID: 26638176 [Abstract] [Full Text] [Related]